The ICGC continues to expand its efforts by incorporating new technologies and methodologies. Future directions include:
Integrating multi-omics data, including proteomics and metabolomics, to provide a more comprehensive view of cancer biology. Exploring the role of non-coding regions of the genome in cancer. Investigating the impact of the microbiome on cancer development and treatment response. Enhancing efforts in rare and understudied cancers to ensure equitable research representation.